WallStSmart

NVIDIA Corporation (NVDA)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

NVIDIA Corporation generates 93127% more annual revenue ($253.49B vs $271.91M). NVDA leads profitability with a 0.6% profit margin vs -14.7%. NVDA earns a higher WallStSmart Score of 80/100 (A-).

NVDA

Exceptional Buy

80

out of 100

Grade: A-

Growth: 6.0Profit: 5.5Value: 4.7Quality: 8.5
Piotroski: 3/9Altman Z: 6.75

ZEPP

Hold

42

out of 100

Grade: D

Growth: 7.3Profit: 2.0Value: 5.0Quality: 4.0
Piotroski: 6/9Altman Z: 0.63
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NVDASignificantly Overvalued (-75.0%)

Margin of Safety

-75.0%

Fair Value

$119.30

Current Price

$206.84

$87.54 premium

UndervaluedFair: $119.30Overvalued

Intrinsic value data unavailable for ZEPP.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NVDA6 strengths · Avg: 9.7/10
Market CapQuality
$5.01T10/10

Mega-cap, among the largest globally

Return on EquityProfitability
81.7%10/10

Every $100 of equity generates 82 in profit

Debt/EquityHealth
0.0710/10

Conservative balance sheet, low leverage

Free Cash FlowQuality
$48.59B10/10

Generating 48.6B in free cash flow

Altman Z-ScoreHealth
6.7510/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.588/10

Growing faster than its price suggests

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
0.4x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
33.8%10/10

Revenue surging 33.8% year-over-year

Areas to Watch

NVDA4 concerns · Avg: 3.8/10
P/E RatioValuation
32.0x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
0.9%4/10

0.9% revenue growth

EPS GrowthGrowth
2.1%4/10

2.1% earnings growth

Profit MarginProfitability
0.6%3/10

0.6% margin — thin

ZEPP4 concerns · Avg: 2.5/10
Market CapQuality
$79.19M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.233/10

Elevated debt levels

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Comparative Analysis Report

WallStSmart Research

Bull Case : NVDA

The strongest argument for NVDA centers on Market Cap, Return on Equity, Debt/Equity. PEG of 0.58 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 33.8% demonstrates continued momentum.

Bear Case : NVDA

The primary concerns for NVDA are P/E Ratio, Revenue Growth, EPS Growth. Thin 0.6% margins leave little buffer for downturns.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Debt/Equity, Return on Equity.

Key Dynamics to Monitor

NVDA profiles as a value stock while ZEPP is a hypergrowth play — different risk/reward profiles.

NVDA carries more volatility with a beta of 2.21 — expect wider price swings.

ZEPP is growing revenue faster at 33.8% — sustainability is the question.

NVDA generates stronger free cash flow (48.6B), providing more financial flexibility.

Bottom Line

NVDA scores higher overall (80/100 vs 42/100). Both earn "Exceptional Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

NVIDIA Corporation

TECHNOLOGY · SEMICONDUCTORS · USA

Nvidia Corporation is an American multinational technology company incorporated in Delaware and based in Santa Clara, California. It designs graphics processing units (GPUs) for the gaming and professional markets, as well as system on a chip units (SoCs) for the mobile computing and automotive market.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?